Home > Publications database > Integrin beta 1 facilitates non-enveloped hepatitis E virus cell entry through the recycling endosome. > print |
001 | 302284 | ||
005 | 20250819093553.0 | ||
024 | 7 | _ | |a 10.1038/s41467-025-61071-y |2 doi |
024 | 7 | _ | |a pmid:40571699 |2 pmid |
024 | 7 | _ | |a altmetric:178396750 |2 altmetric |
037 | _ | _ | |a DKFZ-2025-01303 |
041 | _ | _ | |a English |
082 | _ | _ | |a 500 |
100 | 1 | _ | |a Fu, Rebecca |0 P:(DE-HGF)0 |b 0 |
245 | _ | _ | |a Integrin beta 1 facilitates non-enveloped hepatitis E virus cell entry through the recycling endosome. |
260 | _ | _ | |a [London] |c 2025 |b Springer Nature |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1755588931_6399 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Hepatitis E virus (HEV) is a major cause of acute hepatitis and mainly transmitted faecal-orally. HEV particles present in faeces are naked (nHEV), whereas those found in the blood are quasi-enveloped (eHEV) with a cell-derived lipid membrane. Despite its global health impact, the cellular life cycle of HEV remains poorly understood, particularly regarding the mechanisms of viral entry into host cells. To address this knowledge gap, we develop a high content RNA-FISH-based imaging assay that allows for the investigation of the entry pathways of both naked and quasi-enveloped HEV particles. Surprisingly, we find that integrin α3, previously implicated in nHEV cell entry, is not expressed in the cell types that are most permissive for HEV infection. Instead, we identify integrin β1 (ITGB1) pairing with different α-integrins as the key player mediating nHEV cell entry. Our results indicate that the interaction of nHEV with ITGB1 facilitates entry through Rab11-positive recycling endosomes. In contrast, eHEV particles do not interact with ITGB1 and enter cells using a classical endocytic route via Rab5a-positive early endosomes. The entry of both types of HEV particles requires endosomal acidification and proteolytic cleavage by lysosomal cathepsins, which ultimately results in delivery of the HEV genome to the cytoplasm. |
536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
650 | _ | 7 | |a Integrin beta1 |2 NLM Chemicals |
650 | _ | 7 | |a rab5 GTP-Binding Proteins |0 EC 3.6.5.2 |2 NLM Chemicals |
650 | _ | 7 | |a Itgb1 protein, human |2 NLM Chemicals |
650 | _ | 7 | |a rab11 protein |0 EC 3.6.1.- |2 NLM Chemicals |
650 | _ | 7 | |a rab GTP-Binding Proteins |0 EC 3.6.5.2 |2 NLM Chemicals |
650 | _ | 7 | |a Cathepsins |0 EC 3.4.- |2 NLM Chemicals |
650 | _ | 2 | |a Endosomes: metabolism |2 MeSH |
650 | _ | 2 | |a Endosomes: virology |2 MeSH |
650 | _ | 2 | |a Virus Internalization |2 MeSH |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a Hepatitis E virus: physiology |2 MeSH |
650 | _ | 2 | |a Hepatitis E virus: genetics |2 MeSH |
650 | _ | 2 | |a Integrin beta1: metabolism |2 MeSH |
650 | _ | 2 | |a Integrin beta1: genetics |2 MeSH |
650 | _ | 2 | |a Hepatitis E: virology |2 MeSH |
650 | _ | 2 | |a Hepatitis E: metabolism |2 MeSH |
650 | _ | 2 | |a rab5 GTP-Binding Proteins: metabolism |2 MeSH |
650 | _ | 2 | |a rab GTP-Binding Proteins: metabolism |2 MeSH |
650 | _ | 2 | |a HEK293 Cells |2 MeSH |
650 | _ | 2 | |a Cathepsins: metabolism |2 MeSH |
650 | _ | 2 | |a Lysosomes: metabolism |2 MeSH |
650 | _ | 2 | |a Cell Line |2 MeSH |
700 | 1 | _ | |a Jordan, Paula |b 1 |
700 | 1 | _ | |a Engels, Zoe |b 2 |
700 | 1 | _ | |a Weihs, Jasmin Alara |b 3 |
700 | 1 | _ | |a Mürle, Josias |b 4 |
700 | 1 | _ | |a Chi, Huanting |0 0000-0002-2347-8782 |b 5 |
700 | 1 | _ | |a Burbano de Lara, Sebastian |0 0000-0002-5364-2686 |b 6 |
700 | 1 | _ | |a Helm, Barbara |0 P:(DE-He78)1c49e2bc4134e93b5dc7d9845e30c039 |b 7 |u dkfz |
700 | 1 | _ | |a Klöhn, Mara |b 8 |
700 | 1 | _ | |a Hu, Jungen |b 9 |
700 | 1 | _ | |a Freistaedter, Andrew |b 10 |
700 | 1 | _ | |a Boettler, Tobias |0 0000-0002-1195-055X |b 11 |
700 | 1 | _ | |a Binder, Marco |0 P:(DE-He78)2fb2bd9048a3777dddc4cb89b115c187 |b 12 |u dkfz |
700 | 1 | _ | |a Klingmüller, Ursula |0 P:(DE-He78)860df4ab16c373fb28a815dcd81107a6 |b 13 |u dkfz |
700 | 1 | _ | |a Steinmann, Eike |b 14 |
700 | 1 | _ | |a Lozach, Pierre-Yves |0 0000-0002-9966-1452 |b 15 |
700 | 1 | _ | |a Tubiana, Thibault |0 0000-0002-6490-4602 |b 16 |
700 | 1 | _ | |a Lemon, Stanley M |0 0000-0003-1450-806X |b 17 |
700 | 1 | _ | |a Dao Thi, Viet Loan |0 0000-0003-2293-3592 |b 18 |
773 | _ | _ | |a 10.1038/s41467-025-61071-y |g Vol. 16, no. 1, p. 5403 |0 PERI:(DE-600)2553671-0 |n 1 |p 5403 |t Nature Communications |v 16 |y 2025 |x 2041-1723 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:302284 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 0 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 0000-0002-5364-2686 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)1c49e2bc4134e93b5dc7d9845e30c039 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)2fb2bd9048a3777dddc4cb89b115c187 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)860df4ab16c373fb28a815dcd81107a6 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
914 | 1 | _ | |y 2025 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT COMMUN : 2022 |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2024-01-30T07:48:07Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2024-01-30T07:48:07Z |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Peer review |d 2024-01-30T07:48:07Z |
915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2024-01-30T07:48:07Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1060 |2 StatID |b Current Contents - Agriculture, Biology and Environmental Sciences |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2025-01-02 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-01-02 |
915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b NAT COMMUN : 2022 |d 2025-01-02 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2025-01-02 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2025-01-02 |
920 | 1 | _ | |0 I:(DE-He78)B200-20160331 |k B200 |l B200 Systembiologie der Signaltransduktion |x 0 |
920 | 1 | _ | |0 I:(DE-He78)D430-20160331 |k D430 |l Virus-assoziierte Karzinogenese |x 1 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)B200-20160331 |
980 | _ | _ | |a I:(DE-He78)D430-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|